An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Some professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the platform has removed violative material and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.
After moments of entering one group, a seller shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly significant medical dangers”.
